Dr. Skapek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1991 - 1994
- San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 1988 - 1991
- Duke University School of MedicineClass of 1988
Certifications & Licensure
- NC State Medical License 2024 - 2024
- TX State Medical License 2011 - 2024
- IL State Medical License 2007 - 2014
- TN State Medical License 1999 - 2007
- MA State Medical License 1991 - 1999
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2008 Aug 04
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response Start of enrollment: 2010 Jul 01
- A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.Bailey A Martin-Giacalone, He Li, Michael E Scheurer, Dana L Casey, Shannon Dugan-Perez, Deborah A Marquez-Do, Donna Muzny, Richard A Gibbs, Donald A Barkauskas, David...> ;JAMA Network Open. 2024 Mar 4
- Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.Funan He, Abhik M Bandyopadhyay, Laura J Klesse, Anna Rogojina, Sang H Chun, Erin Butler, Taylor Hartshorne, Trevor Holland, Dawn Garcia, Korri Weldon, Luz-Nereida Per...> ;Nature Communications. 2023 Nov 22
- Comprehensive characterization of patient-derived xenograft models of pediatric leukemia.Anna Rogojina, Laura J Klesse, Erin Butler, Jiwoong Kim, He Zhang, Xue Xiao, Lei Guo, Qinbo Zhou, Taylor Hartshorne, Dawn Garcia, Korri Weldon, Trevor Holland, Abhik B...> ;Iscience. 2023 Nov 17
- Join now to see all
Press Mentions
- Children’s Health Appoints New Chief of Cardiology for the Heart CenterSeptember 13th, 2021
- UT Southwestern Develops System to Identify Genetic Anomalies Connected to CancerJuly 8th, 2018
- Groundbreaking Genetic Research Could Help Diagnose and Cure Cancer in ChildrenJuly 6th, 2018
- Join now to see all
Grant Support
- TGF 2-2 Controls P19ARF During Eye DevelopmentNational Eye Institute2012
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2012
- TGF 2-2 Controls P19ARF During Eye DevelopmentNational Eye Institute2010–2011
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2007–2011
- Translation Of Predictive Cancer Biomarkers Into Clinical PracticeNational Cancer Institute2009–2010
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2003–2007
- Cell Cycle-Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1999
- Cell Cycle-Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1998
- Cell Cycle Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1995
Hospital Affiliations
- Children's Medical Center DallasDallas, Texas
- University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: